{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Ridgefield",
      "state": "CT",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "86527",
      "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "address_1": "900 Ridgebury Rd",
      "address_2": "N/A",
      "postal_code": "06877-1058",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico",
      "recall_number": "D-0053-2021",
      "product_description": "Catapres (clonidine hydrochloride, USP)  0.3 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0011-01",
      "product_quantity": "N/A",
      "reason_for_recall": "An extraneous peak was observed for dissolution testing.",
      "recall_initiation_date": "20201005",
      "center_classification_date": "20201026",
      "termination_date": "20210929",
      "report_date": "20201104",
      "code_info": "Lot # 954953, EXP Jan 2022"
    }
  ]
}